Corporate$CORT8:01 AM ET

Corcept Therapeutics names Justin Gunn to succeed Maduck as endocrinology division president from Oct 1

By BORSA NewsroomPublished Sep 23, 2026, 8:01 AM EDTUpdated Sep 25, 2026, 2:19 PM EDT

Justin Gunn will succeed Sean Maduck as president of Corcept's endocrinology division, effective Oct 1. Maduck is retiring.

Sentimentneutral 50

Neutral · 50 of 100

Impact10

low · stays off the top drivers

Confidence90%

high confidence · single wire

Eventdeveloping

v1 · alerts feed only

WHAT WE KNOW

Justin Gunn will succeed Sean Maduck as president of Corcept Therapeutics' endocrinology division.